BioMarin shares rise as new VOXZOGO and PALYNZIQ data reinforce market potential

Discover how BioMarin’s latest clinical data on VOXZOGO and PALYNZIQ at ACMG 2025 offers promising insights into rare disease treatments and what it means for ... Read More